Liubomyr Kryskiw
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Liubomyr Kryskiw has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Tetyana Kucher
I. Horbachevsky Ternopil National Medical University
10 shared publications - Liliya Logoyda
Department of Pharmaceutical Chemistry, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine
9 shared publications - Mariana Horyn
I. Horbachevsky Ternopil National Medical University
7 shared publications - Nadiya Zarivna
I. Horbachevsky Ternopil National Medical University
6 shared publications - Olha Poliak
I. Horbachevsky Ternopil National Medical University
6 shared publications - Marjan Piponski
Replek Farm Ltd. Company for pharmaceutical-chemical products, North Macedonia
3 shared publications
Latest Publications
- Open Access
- 30 June 2025
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 18 (2) , 1251-1261
Phytochemical Profiling and Antioxidant Activity of Dracocephalum officinale (Blue-Flowered Form) Cultivated in Ukraine
Dracocephalum officinale (L.) Y.P. Chen & B.T. Drew, previously known by the synonym Hyssopus officinalis L., is an essential oil-bearing plant found in the wild in the Eastern Mediterranean and Central Asia. While its health benefits are primarily based on folklore rather than scientific evidence, it has not been included in any of the world’s Pharmacopoeias. Today, there are numerous subspecies, forms, and chemotypes of this species. This study aimed to investigate the potential medicinal value of a blue-flowered form of Dracocephalum officinale cultivated in Ukraine, based on the results of its phytochemical analysis and DPPH free radical scavenging activity. Gas chromatography-mass spectrometry (GC/MS) analysis was used to ascertain the qualitative content and quantity of volatile chemicals. For the chromatographic analysis of phenolic acids, a high-performance liquid chromatography (HPLC) method was employed. The herb was extracted using 80% methanol in an ultrasonic bath at 45°C both for HPLC analysis and spectrophotometric assay of antioxidant activity using 2,2-Diphenyl-1-picrylhydrazyl (DPPH). A total of 40 volatile compounds were identified in the essential oil of Dracocephalum officinale using GC/MS. The primary components of the essential oil included pinocamphone (27.55%), isopinocamphone (15.55%), β-pinene (7.68%), germacrene D (4.76%), α-sabinene (4.62%), myrtenol (4.32%), and γ-elemene (4.10%). High-performance liquid chromatography (HPLC) analysis revealed the presence of nine phenolic acids in an 80% methanolic extract of the studied herb, with rosmarinic acid (19.942 mg/g) and caffeic acid (2.851 mg/g) being the most prevalent. The study conducted on the antioxidant effect of the Dracocephalum officinale extract found a moderate scavenging effect on DPPH free radicals, with the IC50 value of 1.65 mg/mL. This study concludes that further pharmacological research and the development of phytochemicals from Dracocephalum officinale in different dosage forms represent promising areas for future investigation.
- 30 June 2025
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 18 (2) , 1251-1261
Open AccessPhytochemical Profiling and Antioxidant Activity of Dracocephalum officinale (Blue-Flowered Form) Cultivated in Ukraine
Dracocephalum officinale (L.) Y.P. Chen & B.T. Drew, previously known by the synonym Hyssopus officinalis L., is an essential oil-bearing plant found in the wild in the Eastern Mediterranean and Central Asia. While its health benefits are primarily based on folklore rather than scientific evidence, it has not been included in any of the world’s Pharmacopoeias. Today, there are numerous subspecies, forms, and chemotypes of this species. This study aimed to investigate the potential medicinal value of a blue-flowered form of Dracocephalum officinale cultivated in Ukraine, based on the results of its phytochemical analysis and DPPH free radical scavenging activity. Gas chromatography-mass spectrometry (GC/MS) analysis was used to ascertain the qualitative content and quantity of volatile chemicals. For the chromatographic analysis of phenolic acids, a high-performance liquid chromatography (HPLC) method was employed. The herb was extracted using 80% methanol in an ultrasonic bath at 45°C both for HPLC analysis and spectrophotometric assay of antioxidant activity using 2,2-Diphenyl-1-picrylhydrazyl (DPPH). A total of 40 volatile compounds were identified in the essential oil of Dracocephalum officinale using GC/MS. The primary components of the essential oil included pinocamphone (27.55%), isopinocamphone (15.55%), β-pinene (7.68%), germacrene D (4.76%), α-sabinene (4.62%), myrtenol (4.32%), and γ-elemene (4.10%). High-performance liquid chromatography (HPLC) analysis revealed the presence of nine phenolic acids in an 80% methanolic extract of the studied herb, with rosmarinic acid (19.942 mg/g) and caffeic acid (2.851 mg/g) being the most prevalent. The study conducted on the antioxidant effect of the Dracocephalum officinale extract found a moderate scavenging effect on DPPH free radicals, with the IC50 value of 1.65 mg/mL. This study concludes that further pharmacological research and the development of phytochemicals from Dracocephalum officinale in different dosage forms represent promising areas for future investigation.
- Open Access
- 30 June 2025
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 3 (55),p. 30-37
Spectrophotometric determination of nimodipine, nitrendipine, lacidipine in tablets via derivatization with para-dimethylaminobenzaldehyde
The proposed approach involves the interaction of NIM, NIT, and LAC directly with DABA reagent to produce coloured products with its further spectrophotometric analysis by the development of simple, available, and alternative spectrophotometric methods. Material and methods: UV-visible double beam spectrophotometer Shimadzu UV-1800 (Japan) with included UV-Probe version 2.62 software was employed. Additional equipment included a precise analytical balance RAD WAG AS 200/C (Poland), an ultrasonic bath Elmasonic EASY 60H with a frequency of 40 kHz and a water bath VB-4 were used in the developed procedure. LAC, NIM and NIT (purity ≥98% (HPLC)) were supplied from Sigma-Aldrich Chemicals Co. (St. Louis, MO, USA). NIT 10 mg tablets, NIM 30 mg tablets were purchased from local drugstore. LAC 2 mg tablets were purchased from europharm.com.ua. Methanol was produced by Honeywell and had a purity of 99.9%. HCl conc. (fuming, by Sigma Aldrich was used. DABA utilized in the experiment was analytical grade. Results and discussion: Simple, available and alternative visible spectrophotometric methods for the determination of nitrendipine (NIT), nimodipine (NIM), and lacidipine (LAC) in tablets through derivatization with the para-dimethylaminobenzaldehyde (DABA) have been developed. The optimal parameters for CCBs spectrophotometric analysis were as follows: detection wavelength - 577 nm for NIM, NIT and 616 nm for LAC, concentrated hydrochloric acid, 1.5 mL of 0.1% DABA solution, 15 min boiling at 100 °C. The concentration was linearly proportional to absorbance values in the range of 25 – 175 μg/mL (NIT), 25 – 200 μg/mL (NIM), 20 – 200 μg/mL (LAC). Estimation of LOD and LOQ parameters were obtained as 3.75 μg/mL and 11.38 μg/mL (NIT), 4.43 μg/mL and 13.43 μg/mL (NIM), 6.30μg/ml and 19.1μg/mL (LAC). Conclusions. In this work, thorough scientific research was carried out with the presentation of the method of selection of the optimal reaction conditions and spectrophotometric methods for determining NIT, NIM, and LAC in tablets were developed. In addition, the three studied CCBs were quantified using easy-to-implement, simple, cost-effective spectrophotometric approaches. The proposed methods can be used as alternatives and arbitrage, which significantly expands the bank of analytical methods. Moreover, the described methods can be easily implemented for routine pharmaceutical analysis
- 30 June 2025
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 3 (55),p. 30-37
Open AccessSpectrophotometric determination of nimodipine, nitrendipine, lacidipine in tablets via derivatization with para-dimethylaminobenzaldehyde
The proposed approach involves the interaction of NIM, NIT, and LAC directly with DABA reagent to produce coloured products with its further spectrophotometric analysis by the development of simple, available, and alternative spectrophotometric methods. Material and methods: UV-visible double beam spectrophotometer Shimadzu UV-1800 (Japan) with included UV-Probe version 2.62 software was employed. Additional equipment included a precise analytical balance RAD WAG AS 200/C (Poland), an ultrasonic bath Elmasonic EASY 60H with a frequency of 40 kHz and a water bath VB-4 were used in the developed procedure. LAC, NIM and NIT (purity ≥98% (HPLC)) were supplied from Sigma-Aldrich Chemicals Co. (St. Louis, MO, USA). NIT 10 mg tablets, NIM 30 mg tablets were purchased from local drugstore. LAC 2 mg tablets were purchased from europharm.com.ua. Methanol was produced by Honeywell and had a purity of 99.9%. HCl conc. (fuming, by Sigma Aldrich was used. DABA utilized in the experiment was analytical grade. Results and discussion: Simple, available and alternative visible spectrophotometric methods for the determination of nitrendipine (NIT), nimodipine (NIM), and lacidipine (LAC) in tablets through derivatization with the para-dimethylaminobenzaldehyde (DABA) have been developed. The optimal parameters for CCBs spectrophotometric analysis were as follows: detection wavelength - 577 nm for NIM, NIT and 616 nm for LAC, concentrated hydrochloric acid, 1.5 mL of 0.1% DABA solution, 15 min boiling at 100 °C. The concentration was linearly proportional to absorbance values in the range of 25 – 175 μg/mL (NIT), 25 – 200 μg/mL (NIM), 20 – 200 μg/mL (LAC). Estimation of LOD and LOQ parameters were obtained as 3.75 μg/mL and 11.38 μg/mL (NIT), 4.43 μg/mL and 13.43 μg/mL (NIM), 6.30μg/ml and 19.1μg/mL (LAC). Conclusions. In this work, thorough scientific research was carried out with the presentation of the method of selection of the optimal reaction conditions and spectrophotometric methods for determining NIT, NIM, and LAC in tablets were developed. In addition, the three studied CCBs were quantified using easy-to-implement, simple, cost-effective spectrophotometric approaches. The proposed methods can be used as alternatives and arbitrage, which significantly expands the bank of analytical methods. Moreover, the described methods can be easily implemented for routine pharmaceutical analysis
- Open Access
- 30 August 2024
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 4 (50),p. 4-13
Full green assay of rosuvastatin utilizing sulphophtalein dyes: application to tablet analysis
The aim of the work was to develop a «green» and extraction-free spectrophotometric procedure for the assay of rosuvastatin in tablets. The present work describes three new spectrophotometric procedures (A, B and C) that can be utilized for routine quality control of rosuvastatin in laboratories. Materials and methods. Analytical instrumentation: Shimadzu UV-1800 double beam UV-vis spectrophotometer (Japan) with attached UV-Probe ver. 2.62 software, RAD WAG AS 200/C precise analytical balance (Poland). Rosuvastatin calcium (purity ≥98 % (HPLC)) was bought from Sigma-Aldrich Chemicals Co. (St. Louis, MO, USA). Rosuvastatin 10 mg tablets were acquired from a nearby drugstore. All solvents used in this study, including methanol, ethanol, chloroform, acetonitrile and ethyl acetate, were produced by Honeywell and had a purity of 99.9 %. BCG, BCP and BTB were acquired from Sigma-Aldrich Chemicals Co. (USA, St. Louis). All chemicals utilized in the experiment were of analytical purity. Results and discussion. New simple «green» and extraction-free spectrophotometric procedures for assay of rosuvastatin in tablets involve the formation of ion-pair complexes with sulphophtalein dyes (BCG (Method A), BCP (Method B), BTB (Method C)) have been developed. The absorbances of the coloured reaction products were registered at 405 nm (Method A) and 400 nm (Methods B, C). The concentration was linearly proportional to absorbance values in the range of 2.51-20.08 μg/mL (method A), 2.50-24.90 μg/mL (method B) and 2.51-12.56 μg/mL (method C). Estimation of LOD and LOQ parameters were obtained as 0.67 μg/mL and 2.23 μg/mL (Method A), 0.39 μg/mL and 1.32 μg/mL (Method B), 0.30 μg/mL and 1.01 μg/mL (Method C). The stoichiometric ratio of the reactive components of rosuvastatin - BCG, BCP, and BTB corresponded 1: 1. The %RSD values of intra-day and inter-day were obtained less than < 1.5 %, which showed excellent repeatability and RE % data was ≤ 3 %. The effect on the environment of the proposed spectrophotometric procedures and their compliance with the GAC principles were endorsed by the output of AGREE, GAPI, and AES metrics tools. The values of these three «green» metrics show that the proposed spectrophotometric procedures had a low environmental impact compared with the reported ones. Conclusions. The developed fast, simple and cost-effective methods A, B, and C can be used for routine analysis of rosuvastatin in tablets
- 30 August 2024
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 4 (50),p. 4-13
Open AccessFull green assay of rosuvastatin utilizing sulphophtalein dyes: application to tablet analysis
The aim of the work was to develop a «green» and extraction-free spectrophotometric procedure for the assay of rosuvastatin in tablets. The present work describes three new spectrophotometric procedures (A, B and C) that can be utilized for routine quality control of rosuvastatin in laboratories. Materials and methods. Analytical instrumentation: Shimadzu UV-1800 double beam UV-vis spectrophotometer (Japan) with attached UV-Probe ver. 2.62 software, RAD WAG AS 200/C precise analytical balance (Poland). Rosuvastatin calcium (purity ≥98 % (HPLC)) was bought from Sigma-Aldrich Chemicals Co. (St. Louis, MO, USA). Rosuvastatin 10 mg tablets were acquired from a nearby drugstore. All solvents used in this study, including methanol, ethanol, chloroform, acetonitrile and ethyl acetate, were produced by Honeywell and had a purity of 99.9 %. BCG, BCP and BTB were acquired from Sigma-Aldrich Chemicals Co. (USA, St. Louis). All chemicals utilized in the experiment were of analytical purity. Results and discussion. New simple «green» and extraction-free spectrophotometric procedures for assay of rosuvastatin in tablets involve the formation of ion-pair complexes with sulphophtalein dyes (BCG (Method A), BCP (Method B), BTB (Method C)) have been developed. The absorbances of the coloured reaction products were registered at 405 nm (Method A) and 400 nm (Methods B, C). The concentration was linearly proportional to absorbance values in the range of 2.51-20.08 μg/mL (method A), 2.50-24.90 μg/mL (method B) and 2.51-12.56 μg/mL (method C). Estimation of LOD and LOQ parameters were obtained as 0.67 μg/mL and 2.23 μg/mL (Method A), 0.39 μg/mL and 1.32 μg/mL (Method B), 0.30 μg/mL and 1.01 μg/mL (Method C). The stoichiometric ratio of the reactive components of rosuvastatin - BCG, BCP, and BTB corresponded 1: 1. The %RSD values of intra-day and inter-day were obtained less than < 1.5 %, which showed excellent repeatability and RE % data was ≤ 3 %. The effect on the environment of the proposed spectrophotometric procedures and their compliance with the GAC principles were endorsed by the output of AGREE, GAPI, and AES metrics tools. The values of these three «green» metrics show that the proposed spectrophotometric procedures had a low environmental impact compared with the reported ones. Conclusions. The developed fast, simple and cost-effective methods A, B, and C can be used for routine analysis of rosuvastatin in tablets
- Open Access
- 30 June 2024
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 3 (49),p. 47-53
Novel eco-friendly spectrophotometric determination of lercanidipine hydrochloride in tablets using methyl red
The aim of the work was to develop a simple, eco-friendly, quick, affordable and alternative spectrophotometric procedure that uses the azodye methyl red (MR) for the determination of lercanidipine in its dosage form considering the “green” chemistry principles. Materials and methods. Analytical equipment: Shimadzu UV-1800 double beam UV-visible spectrophotometer (Japan) with included UV-Probe 2.70 software, RAD WAG AS 200/C precise analytical balance (Poland), Elmasonic EASY 40H ultrasonic bath. Lercanidipine hydrochloride (purity 99 %) was purchased from Jiyan Chemicals (India). Lercanidipine tablets 10 mg and 20 mg were used in our experiments. Results and discussion. To determine the amount of lercanidipine in tablets, a spectrophotometric method has been developed. To select the best dye for the method development, we tested a variety of dyes, including MR, bromocresol purple, bromophenol blue, cresol red, bromocresol green and bromothymol blue. We selected MR as the reagent based on the experimental studies' outcomes, and the solvent was an acetonitrile and ethanol mixture with a ratio of 95 to 5. The optimal parameters were determined for the quantitation of lercanidipine in tablets utilizing MR with 5×10-5 mol/L of dye concentration, 0.5 ml of MR solution, at a temperature of 25 °C without heating; detection wavelength was 498 nm and reaction time of 5 min. By using the molar ratios (saturation) method and Job's (continuous variations) approach, the stoichiometric coefficients of reacting components involving lercanidipine and dye were established to be 1:1. The proposed spectrophotometric procedure was linear within the concentration ranging from 6.48 – 32.41 μg/mL. Using the least squares method, a regression equation was generated: y = 0.0208x – 0.0318. The correlation coefficient was higher than 0.999, indicating that the analytical procedures' linearity is acceptable; the limit of detection and limit of quantitation were 1.19 μg/mL and 3.62 μg/mL, respectively. The robustness, accuracy and precision of the study results fell within acceptable limits. The proposed method was successfully applied to determine the content of lercanidipine in its tablet dosage forms. The analysis of the method's "greenness" using AGREE and GAPI tools yielded excellent results. Conclusions. The method that has been developed can serve as an alternative approach for the routine control of lercanidipine content in its tablets
- 30 June 2024
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 3 (49),p. 47-53
Open AccessNovel eco-friendly spectrophotometric determination of lercanidipine hydrochloride in tablets using methyl red
The aim of the work was to develop a simple, eco-friendly, quick, affordable and alternative spectrophotometric procedure that uses the azodye methyl red (MR) for the determination of lercanidipine in its dosage form considering the “green” chemistry principles. Materials and methods. Analytical equipment: Shimadzu UV-1800 double beam UV-visible spectrophotometer (Japan) with included UV-Probe 2.70 software, RAD WAG AS 200/C precise analytical balance (Poland), Elmasonic EASY 40H ultrasonic bath. Lercanidipine hydrochloride (purity 99 %) was purchased from Jiyan Chemicals (India). Lercanidipine tablets 10 mg and 20 mg were used in our experiments. Results and discussion. To determine the amount of lercanidipine in tablets, a spectrophotometric method has been developed. To select the best dye for the method development, we tested a variety of dyes, including MR, bromocresol purple, bromophenol blue, cresol red, bromocresol green and bromothymol blue. We selected MR as the reagent based on the experimental studies' outcomes, and the solvent was an acetonitrile and ethanol mixture with a ratio of 95 to 5. The optimal parameters were determined for the quantitation of lercanidipine in tablets utilizing MR with 5×10-5 mol/L of dye concentration, 0.5 ml of MR solution, at a temperature of 25 °C without heating; detection wavelength was 498 nm and reaction time of 5 min. By using the molar ratios (saturation) method and Job's (continuous variations) approach, the stoichiometric coefficients of reacting components involving lercanidipine and dye were established to be 1:1. The proposed spectrophotometric procedure was linear within the concentration ranging from 6.48 – 32.41 μg/mL. Using the least squares method, a regression equation was generated: y = 0.0208x – 0.0318. The correlation coefficient was higher than 0.999, indicating that the analytical procedures' linearity is acceptable; the limit of detection and limit of quantitation were 1.19 μg/mL and 3.62 μg/mL, respectively. The robustness, accuracy and precision of the study results fell within acceptable limits. The proposed method was successfully applied to determine the content of lercanidipine in its tablet dosage forms. The analysis of the method's "greenness" using AGREE and GAPI tools yielded excellent results. Conclusions. The method that has been developed can serve as an alternative approach for the routine control of lercanidipine content in its tablets
- Open Access
- 30 April 2024
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 2 (48),p. 44-52
Two masterful alternative spectrophotometric methods for the determination of ramipril in tablets
The aim of the work was to develop two simple, rapid, economic, alternative spectrophotometric methods for the determination of ramipril in tablets based on the reaction with sulfonephthalein dyes (bromphenol blue (BPB) and cresol red (CR)). Materials and methods. Analytical instrumentation: Shimadzu UV-1800 double beam UV-VIS spectrophotometer (Japan) with attached UV-Probe ver. 2.62 software, RAD WAG AS 200/C precise analytical balance (Poland). Ramipril (purity ≥98 % (HPLC)) was purchased from AARTI Industries Limited (India). Ramipril tablets 5 mg and 10 mg were purchased from a local pharmacy. Results and discussion. Two spectrophotometric methods for the determination of ramipril in tablets have been developed. We have tested various sulfophthalein dyes (BPB, bromocresol green, bromthymol blue, thymol blue, CR) in order to choose the optimal for the method development. According to the results of the experimental studies, we chose BPB and CR as reagents, and the solvent was acetonitrile for both methods. The optimal conditions for the quantitative determination of ramipril in tabletsy using BPB were established: dye concentration - 2.35×10-4 mol/L, volume of BPB solution – 1.0 ml, without heating, wavelength – 598 nm, reaction time – 5 min, temperature of the solution – 25 °C. The optimal conditions for the quantitative determination of ramipril in tabletsusing CR were established: dye 1.33×10-4 mol/L, volume of CR solution – 1.0 ml, without heating, wavelength – 395 nm, reaction time – 5 min, temperature of the solution – 25 °C. The spectrophotometric method by using BPB was linear in the concentration range of 1.99-5.96 µg/mL, LOD – 0.20 µg/mL, LOQ – 0.60 µg/mL. The spectrophotometric method using CR was linear in the concentration range of 0.42-5.44 µg/mL, LOD – 0.10 µg/mL, and LOQ – 0.36 µg/mL. The results of the study on robustness, accuracy, and precision were within the acceptance criteria. The results of studying the «greenness» of both methods indicate an excellent «green» analysis.Conclusions. Developed methods can be used as an alternative method for the routine analysis of ramipril tablets
- 30 April 2024
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 2 (48),p. 44-52
Open AccessTwo masterful alternative spectrophotometric methods for the determination of ramipril in tablets
The aim of the work was to develop two simple, rapid, economic, alternative spectrophotometric methods for the determination of ramipril in tablets based on the reaction with sulfonephthalein dyes (bromphenol blue (BPB) and cresol red (CR)). Materials and methods. Analytical instrumentation: Shimadzu UV-1800 double beam UV-VIS spectrophotometer (Japan) with attached UV-Probe ver. 2.62 software, RAD WAG AS 200/C precise analytical balance (Poland). Ramipril (purity ≥98 % (HPLC)) was purchased from AARTI Industries Limited (India). Ramipril tablets 5 mg and 10 mg were purchased from a local pharmacy. Results and discussion. Two spectrophotometric methods for the determination of ramipril in tablets have been developed. We have tested various sulfophthalein dyes (BPB, bromocresol green, bromthymol blue, thymol blue, CR) in order to choose the optimal for the method development. According to the results of the experimental studies, we chose BPB and CR as reagents, and the solvent was acetonitrile for both methods. The optimal conditions for the quantitative determination of ramipril in tabletsy using BPB were established: dye concentration - 2.35×10-4 mol/L, volume of BPB solution – 1.0 ml, without heating, wavelength – 598 nm, reaction time – 5 min, temperature of the solution – 25 °C. The optimal conditions for the quantitative determination of ramipril in tabletsusing CR were established: dye 1.33×10-4 mol/L, volume of CR solution – 1.0 ml, without heating, wavelength – 395 nm, reaction time – 5 min, temperature of the solution – 25 °C. The spectrophotometric method by using BPB was linear in the concentration range of 1.99-5.96 µg/mL, LOD – 0.20 µg/mL, LOQ – 0.60 µg/mL. The spectrophotometric method using CR was linear in the concentration range of 0.42-5.44 µg/mL, LOD – 0.10 µg/mL, and LOQ – 0.36 µg/mL. The results of the study on robustness, accuracy, and precision were within the acceptance criteria. The results of studying the «greenness» of both methods indicate an excellent «green» analysis.Conclusions. Developed methods can be used as an alternative method for the routine analysis of ramipril tablets
- Open Access
- 30 April 2023
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 2(42),p. 11-19
Development of the spectrophotometric method for the determination of rosuvastatin in tablets by using bromophenol blue
The aim of the work was to develop a spectrophotometric method for the determination of rosuvastatin in tablets based on the reaction with BPB in compliance with the principles of «green» chemistry. Material and methods. Analytical equipment: two-beam UV-visible spectrophotometer Shimadzu model -UV 1800 (Japan), software UV-Probe 2.62, electronic laboratory balance RAD WAG AS 200/C. The following APIs, dosage forms, reagents and solvents were used in work: pharmacopoeial standard sample (CRS) of rosuvastatin calcium (Sigma-Aldrich, (≥ 98 %, HPLC)), BCG (Sigma-Aldrich, (≥ 98 %, HPLC)), "Rosuvastatin" tablets 10 mg, 15 mg, 20 mg, methanol (Honeywell, (≥ 99.9 %, GC)), ethanol (Honeywell, (≥ 99.9 %, GC)), chloroform (Honeywell, (≥ 99.9 %, GC)), acetonitrile (Honeywell, (≥ 99.9 %, GC)), and ethyl acetate (Honeywell, (≥ 99.7 %, GC)). Results and discussion. A spectrophotometric method for determining rosuvastatin by reaction with BPB in an acetonitrile solution using the absorption maximum at a wavelength of 595 nm has been developed. Stoichiometric ratios of reactive components were established, which were 1:1. The developed method for the quantitative determination of rosuvastatin was validated following the requirements of the SPhU. The analytical method was linear in the 7.99-23.97 μmol/L concentration range. The LOD and LOQ values were calculated to be 0.77 µmol/L and 2.36 µmol/L. According to the «greenness» pictogram of the analytical method using the AGREE method, the score was 0.77, indicating that the proposed spectrophotometric method for determining rosuvastatin was developed in compliance with the principles of «green» chemistry. Conclusions. An eco-friendly spectrophotometric method has been developed to quantitatively determine rosuvastatin in tablets based on the reaction with BPB. The appropriate sulfophthalein dye (BPB) and its concentration (4.00 x 10-4), the optimal eco-friendly solvent (acetonitrile), and the appropriate wavelength (595 nm) were chosen, and the sensitivity of the reaction was calculated. The analytical method was validated, and its possibility for use in the pharmaceutical analysis was shown
- 30 April 2023
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 2(42),p. 11-19
Open AccessDevelopment of the spectrophotometric method for the determination of rosuvastatin in tablets by using bromophenol blue
The aim of the work was to develop a spectrophotometric method for the determination of rosuvastatin in tablets based on the reaction with BPB in compliance with the principles of «green» chemistry. Material and methods. Analytical equipment: two-beam UV-visible spectrophotometer Shimadzu model -UV 1800 (Japan), software UV-Probe 2.62, electronic laboratory balance RAD WAG AS 200/C. The following APIs, dosage forms, reagents and solvents were used in work: pharmacopoeial standard sample (CRS) of rosuvastatin calcium (Sigma-Aldrich, (≥ 98 %, HPLC)), BCG (Sigma-Aldrich, (≥ 98 %, HPLC)), "Rosuvastatin" tablets 10 mg, 15 mg, 20 mg, methanol (Honeywell, (≥ 99.9 %, GC)), ethanol (Honeywell, (≥ 99.9 %, GC)), chloroform (Honeywell, (≥ 99.9 %, GC)), acetonitrile (Honeywell, (≥ 99.9 %, GC)), and ethyl acetate (Honeywell, (≥ 99.7 %, GC)). Results and discussion. A spectrophotometric method for determining rosuvastatin by reaction with BPB in an acetonitrile solution using the absorption maximum at a wavelength of 595 nm has been developed. Stoichiometric ratios of reactive components were established, which were 1:1. The developed method for the quantitative determination of rosuvastatin was validated following the requirements of the SPhU. The analytical method was linear in the 7.99-23.97 μmol/L concentration range. The LOD and LOQ values were calculated to be 0.77 µmol/L and 2.36 µmol/L. According to the «greenness» pictogram of the analytical method using the AGREE method, the score was 0.77, indicating that the proposed spectrophotometric method for determining rosuvastatin was developed in compliance with the principles of «green» chemistry. Conclusions. An eco-friendly spectrophotometric method has been developed to quantitatively determine rosuvastatin in tablets based on the reaction with BPB. The appropriate sulfophthalein dye (BPB) and its concentration (4.00 x 10-4), the optimal eco-friendly solvent (acetonitrile), and the appropriate wavelength (595 nm) were chosen, and the sensitivity of the reaction was calculated. The analytical method was validated, and its possibility for use in the pharmaceutical analysis was shown
- Open Access
- 28 February 2023
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 1(41),p. 14-22
Application of salts of chaotropic anions in the development of hplc methods for the determination of meldonium in dosage forms
The aim of the work was to create an approach for the development of HPLC methods for the determination of meldonium in dosage forms with the usage of salts of chaotropic anions in mobile phases. Material and methods. Analytical equipment: Shimadzu UPLC system LC-40 PDA; Shimadzu Nexera-i LC-2040C 3D-Plus, controlled by software Lab Solution version 5.97, electronic laboratory balance RAD WAG AS 200/C, pH-meter I-160MI. Meldonium dihydrate (purity 99.3 %) was purchased from Sigma-Aldrich (Switzerland), and Vasopro capsules 500 mg were purchased from a local pharmacy. Chromatographic conditions: Agilent Zorbax C-18 SB 150 mm x 4.6 mm 3.5 μm column was used (Agilent Technologies, USA). Mobile phases: 1) 0.25 % KPF6 w/v – 0.1 % v/v 85 %H3PO4 95 % – 5 % ACN, 2) 0.3 % bis-(trifluoromethane)sulfonimide lithium salt 97 % w/v – 0.1 %v/v 85 % H3PO4 80 % – 20 % acetonitrile. Flow rate - 1mL/min, T=32 °C, detection UV=at 4 channels - 190 nm, 195 nm, 200 nm, 205 nm. Results and discussion. We have proposed two approaches using two different salts of chaotropic anions - potassium hexafluorophosphate and bis-(trifluoromethane)sulfonimide lithium salt – for the HPLC method development. The chaotropic effects of these anions toward meldonium strongly influenced the analyte migratory behaviour. Both mobile phases involved, in addition to the use of a chaotrope, also the use of acetonitrile and pH adjustment with 0.1 % v/v 85 % H3PO4 solution. The detection wavelength (190 nm, 195 nm, 200 nm, 205 nm) was selected experimentally. The results were obtained for 8 concepts. Parameters of the chromatographic system confirm the conclusions and results of this investigation for the influence of chaotropic salts on N-containing molecules in an acidic pH medium, by increasing their retentivity and improving peak shape and uniformity homogeneity, even on the column without end-capping and base-deactivating. Validation of the analytical method was carried out following the requirements of SPhU. Conclusions. HPLC methods for the determination of meldonium in dosage forms have been developed, using positive impacts of chaotropic salts on the molecules containing N-atoms in their molecule on their retentions and peak symmetries on the chromatogram. The validation of the analytical methods showed their suitability for pharmaceutical analysis
- 28 February 2023
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 1(41),p. 14-22
Open AccessApplication of salts of chaotropic anions in the development of hplc methods for the determination of meldonium in dosage forms
The aim of the work was to create an approach for the development of HPLC methods for the determination of meldonium in dosage forms with the usage of salts of chaotropic anions in mobile phases. Material and methods. Analytical equipment: Shimadzu UPLC system LC-40 PDA; Shimadzu Nexera-i LC-2040C 3D-Plus, controlled by software Lab Solution version 5.97, electronic laboratory balance RAD WAG AS 200/C, pH-meter I-160MI. Meldonium dihydrate (purity 99.3 %) was purchased from Sigma-Aldrich (Switzerland), and Vasopro capsules 500 mg were purchased from a local pharmacy. Chromatographic conditions: Agilent Zorbax C-18 SB 150 mm x 4.6 mm 3.5 μm column was used (Agilent Technologies, USA). Mobile phases: 1) 0.25 % KPF6 w/v – 0.1 % v/v 85 %H3PO4 95 % – 5 % ACN, 2) 0.3 % bis-(trifluoromethane)sulfonimide lithium salt 97 % w/v – 0.1 %v/v 85 % H3PO4 80 % – 20 % acetonitrile. Flow rate - 1mL/min, T=32 °C, detection UV=at 4 channels - 190 nm, 195 nm, 200 nm, 205 nm. Results and discussion. We have proposed two approaches using two different salts of chaotropic anions - potassium hexafluorophosphate and bis-(trifluoromethane)sulfonimide lithium salt – for the HPLC method development. The chaotropic effects of these anions toward meldonium strongly influenced the analyte migratory behaviour. Both mobile phases involved, in addition to the use of a chaotrope, also the use of acetonitrile and pH adjustment with 0.1 % v/v 85 % H3PO4 solution. The detection wavelength (190 nm, 195 nm, 200 nm, 205 nm) was selected experimentally. The results were obtained for 8 concepts. Parameters of the chromatographic system confirm the conclusions and results of this investigation for the influence of chaotropic salts on N-containing molecules in an acidic pH medium, by increasing their retentivity and improving peak shape and uniformity homogeneity, even on the column without end-capping and base-deactivating. Validation of the analytical method was carried out following the requirements of SPhU. Conclusions. HPLC methods for the determination of meldonium in dosage forms have been developed, using positive impacts of chaotropic salts on the molecules containing N-atoms in their molecule on their retentions and peak symmetries on the chromatogram. The validation of the analytical methods showed their suitability for pharmaceutical analysis
- Open Access
- 30 December 2022
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 6(40),p. 29-35
Development of the spectrophotometric method for the determination of metoprolol in tablets by using bromophenol blue
The aim of the work was to develop a simple, economical and eco-friendly spectrophotometric method for determining metoprolol tartrate in tablets based on the reaction with bromophenol blue (BPB). Material and methods: A double–beam Shimadzu UV-Visible spectrophotometer, with a spectral bandwidth of 1 nm wavelength accuracy ±0.5 nm, Model –UV 1800 (Japan), Software UV-Probe 2.62, and a pair of 1 cm matched quartz cells, was used to measure the absorbance of the resulting solution. All the chemicals were used in analytical reagent grade. Pharmacopeial standard samples of metoprolol tartrate and bromophenol blue (BPB) were provided by Sigma-Aldrich (≥ 98%, HPLC). The used dosage forms of metoprolol tartrate are tablets of Metoprolol 50 mg and 100 mg. Results and discussion: The method of spectrophotometric determination of the quantitative content of metoprolol tartrate based on its reaction with BPB in a methanol solution has been developed. The stoichiometric ratios of the reactive components as 1:1 were obtained by the methods of continuous changes and the saturation method. The developed method of quantitative determination of metoprolol tartrate was validated. The linearity regression equation was y = 0.0373x + 0.0038, and the obtained correlation coefficient was R2=0.9984. A linear relationship was found between absorbance at λmax and concentration of metoprolol tartrate in the range of 9.56-15.02 µg/mL. The LOD and LOQ values were calculated to be 0.81 µg/mL and 2.67 µg/mL. Conclusions. A simple, economical and eco-friendly spectrophotometric method has been developed for the quantitative determination of metoprolol tartrate in tablets based on the reaction with BPB. The developed method of quantitative determination of metoprolol tartrate was validated in accordance with the requirements of SPhU. We suggest our work with offered detailed and successful solutions for the mentioned aim with less sophisticated equipment for QC lab for routine manufacturing control
- 30 December 2022
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 6(40),p. 29-35
Open AccessDevelopment of the spectrophotometric method for the determination of metoprolol in tablets by using bromophenol blue
The aim of the work was to develop a simple, economical and eco-friendly spectrophotometric method for determining metoprolol tartrate in tablets based on the reaction with bromophenol blue (BPB). Material and methods: A double–beam Shimadzu UV-Visible spectrophotometer, with a spectral bandwidth of 1 nm wavelength accuracy ±0.5 nm, Model –UV 1800 (Japan), Software UV-Probe 2.62, and a pair of 1 cm matched quartz cells, was used to measure the absorbance of the resulting solution. All the chemicals were used in analytical reagent grade. Pharmacopeial standard samples of metoprolol tartrate and bromophenol blue (BPB) were provided by Sigma-Aldrich (≥ 98%, HPLC). The used dosage forms of metoprolol tartrate are tablets of Metoprolol 50 mg and 100 mg. Results and discussion: The method of spectrophotometric determination of the quantitative content of metoprolol tartrate based on its reaction with BPB in a methanol solution has been developed. The stoichiometric ratios of the reactive components as 1:1 were obtained by the methods of continuous changes and the saturation method. The developed method of quantitative determination of metoprolol tartrate was validated. The linearity regression equation was y = 0.0373x + 0.0038, and the obtained correlation coefficient was R2=0.9984. A linear relationship was found between absorbance at λmax and concentration of metoprolol tartrate in the range of 9.56-15.02 µg/mL. The LOD and LOQ values were calculated to be 0.81 µg/mL and 2.67 µg/mL. Conclusions. A simple, economical and eco-friendly spectrophotometric method has been developed for the quantitative determination of metoprolol tartrate in tablets based on the reaction with BPB. The developed method of quantitative determination of metoprolol tartrate was validated in accordance with the requirements of SPhU. We suggest our work with offered detailed and successful solutions for the mentioned aim with less sophisticated equipment for QC lab for routine manufacturing control
- Open Access
- 30 October 2022
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 5 (39),p. 55-63
Development of the spectrophotometric method for the determination of metoprolol tartrate in tablets by using bromocresol green
The aim of the work was to develop and validate a spectrophotometric method for determining metoprolol tartrate in tablets based on the reaction with bromocresol green (BCG). Material and methods. Analytical equipment: two-beam UV-visible spectrophotometer Shimadzu model -UV 1800 (Japan), software UV-Probe 2.62, laboratory electronic balance RAD WAG AS 200/C, pH-meter И-160МИ. The following APIs, dosage forms, reagents and solvents were used in the work: pharmacopoeial standard sample (CRS) of metoprolol tartrate (Sigma-Aldrich, (≥ 98 %, HPLC)), BCG (Sigma-Aldrich, (≥ 98 %, HPLC)), "Metoprolol" tablets 50 mg (Kyivmedpreparat, series 0035415), "Metoprolol" 100 mg (Farmak, series 30421), methanol (Honeywell, (≥ 99.9 %, GC)), ethanol (Honeywell, (≥ 99.9 %, GC)), chloroform (Honeywell, (≥ 99.9 %, GC)), acetonitrile (Honeywell, (≥ 99.9 %, GC)), and ethyl acetate (Honeywell, (≥ 99.7 %, GC)). Results and discussion. A spectrophotometric method was developed for determining metoprolol tartrate by reaction with BCG in a methanol solution using the absorption maximum at a wavelength of 624 nm. Stoichiometric ratios of reactive components were established, which were 1:1. The developed method for the quantitative determination of metoprolol tartrate was validated following the requirements of the SPhU. The analytical method was linear in the concentration range of 5.47-38.30 μg/mL. The limit of detection and quantification were 0.41 μg/mL and 1.24 μg/mL, respectively. According to the «greenness» pictogram of the analytical method using the AGREE method, the score was 0.79, which indicates that the proposed spectrophotometric method for the determination of metoprolol was developed in compliance with the principles of «green» chemistry.Conclusions. A spectrophotometric method for determining metoprolol tartrate in tablets based on the reaction with BCG in compliance with the principles of «green» chemistry has been developed and validated. Furthermore, the developed method for the quantitative determination of metoprolol tartrate was validated following the requirements of the SPhU. In summary, the developed method has a low negative impact on the environment and can be applied for routine pharmaceutical analysis
- 30 October 2022
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 5 (39),p. 55-63
Open AccessDevelopment of the spectrophotometric method for the determination of metoprolol tartrate in tablets by using bromocresol green
The aim of the work was to develop and validate a spectrophotometric method for determining metoprolol tartrate in tablets based on the reaction with bromocresol green (BCG). Material and methods. Analytical equipment: two-beam UV-visible spectrophotometer Shimadzu model -UV 1800 (Japan), software UV-Probe 2.62, laboratory electronic balance RAD WAG AS 200/C, pH-meter И-160МИ. The following APIs, dosage forms, reagents and solvents were used in the work: pharmacopoeial standard sample (CRS) of metoprolol tartrate (Sigma-Aldrich, (≥ 98 %, HPLC)), BCG (Sigma-Aldrich, (≥ 98 %, HPLC)), "Metoprolol" tablets 50 mg (Kyivmedpreparat, series 0035415), "Metoprolol" 100 mg (Farmak, series 30421), methanol (Honeywell, (≥ 99.9 %, GC)), ethanol (Honeywell, (≥ 99.9 %, GC)), chloroform (Honeywell, (≥ 99.9 %, GC)), acetonitrile (Honeywell, (≥ 99.9 %, GC)), and ethyl acetate (Honeywell, (≥ 99.7 %, GC)). Results and discussion. A spectrophotometric method was developed for determining metoprolol tartrate by reaction with BCG in a methanol solution using the absorption maximum at a wavelength of 624 nm. Stoichiometric ratios of reactive components were established, which were 1:1. The developed method for the quantitative determination of metoprolol tartrate was validated following the requirements of the SPhU. The analytical method was linear in the concentration range of 5.47-38.30 μg/mL. The limit of detection and quantification were 0.41 μg/mL and 1.24 μg/mL, respectively. According to the «greenness» pictogram of the analytical method using the AGREE method, the score was 0.79, which indicates that the proposed spectrophotometric method for the determination of metoprolol was developed in compliance with the principles of «green» chemistry.Conclusions. A spectrophotometric method for determining metoprolol tartrate in tablets based on the reaction with BCG in compliance with the principles of «green» chemistry has been developed and validated. Furthermore, the developed method for the quantitative determination of metoprolol tartrate was validated following the requirements of the SPhU. In summary, the developed method has a low negative impact on the environment and can be applied for routine pharmaceutical analysis
- Open Access
- 31 August 2022
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 4 (38),p. 89-97
Development of the spectrophotometric method for the determination of atorvastatin in tablets by using bromothymol blue
The aim of the work was to develop a simple, economic, fast, reliable, and eco-friendly spectrophotometric method for the determination of atorvastatin in tablets based on the reaction with bromothymol blue (BTB). Material and methods. A double–beam Shimadzu UV-Visible spectrophotometer, with spectral bandwidth of 1 nm wavelength accuracy ±0.5 nm, Model –UV 1800 (Japan), Software UV-Probe 2.62 was used to measure absorbance of the resulting solution. Pharmacopeial standard sample of atorvastatin calcium and BTB were provided by Sigma-Aldrich (≥98 %, HPLC). The used dosage forms of atorvastatin: tablets Atorvastatin 10 mg and 20 mg. Results and discussion. The method of spectrophotometric determination of the quantitative content of atorvastatin calcium based on its reaction with BTB in ethyl acetate medium has been developed. The stoichiometric ratios of the reactive components as 1:1 were obtained by the methods of continuous changes and the saturation method. Linearity regression equation was y=0.0017x+0.0496 and the obtained correlation coefficient was R2=0.9993. The linear relationship was found between absorbance at λmax and concentration of medicine in the range 15.48–154.80 µg/mL. The LOD and LOQ values were calculated to be 4.85 µg/mL and 14.71 µg/mL respectively. Spectrophotometric method for the determination of atorvastatin in tablets using BTB was developed in accordance with GAC principles. Conclusions. A simple, economic, fast, reliable and eco-friendly spectrophotometric method was developed for the determination of atorvastatin calcium in tablets based on the reaction with BTB and validated according to the standardized validation procedure by the standard method. It was proved that according to such validation characteristics as linearity, precision, accuracy, and robustness the proposed method met the requirements of SPhU
- 31 August 2022
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 4 (38),p. 89-97
Open AccessDevelopment of the spectrophotometric method for the determination of atorvastatin in tablets by using bromothymol blue
The aim of the work was to develop a simple, economic, fast, reliable, and eco-friendly spectrophotometric method for the determination of atorvastatin in tablets based on the reaction with bromothymol blue (BTB). Material and methods. A double–beam Shimadzu UV-Visible spectrophotometer, with spectral bandwidth of 1 nm wavelength accuracy ±0.5 nm, Model –UV 1800 (Japan), Software UV-Probe 2.62 was used to measure absorbance of the resulting solution. Pharmacopeial standard sample of atorvastatin calcium and BTB were provided by Sigma-Aldrich (≥98 %, HPLC). The used dosage forms of atorvastatin: tablets Atorvastatin 10 mg and 20 mg. Results and discussion. The method of spectrophotometric determination of the quantitative content of atorvastatin calcium based on its reaction with BTB in ethyl acetate medium has been developed. The stoichiometric ratios of the reactive components as 1:1 were obtained by the methods of continuous changes and the saturation method. Linearity regression equation was y=0.0017x+0.0496 and the obtained correlation coefficient was R2=0.9993. The linear relationship was found between absorbance at λmax and concentration of medicine in the range 15.48–154.80 µg/mL. The LOD and LOQ values were calculated to be 4.85 µg/mL and 14.71 µg/mL respectively. Spectrophotometric method for the determination of atorvastatin in tablets using BTB was developed in accordance with GAC principles. Conclusions. A simple, economic, fast, reliable and eco-friendly spectrophotometric method was developed for the determination of atorvastatin calcium in tablets based on the reaction with BTB and validated according to the standardized validation procedure by the standard method. It was proved that according to such validation characteristics as linearity, precision, accuracy, and robustness the proposed method met the requirements of SPhU